Sintx Technologies - SINT Profit before deduction of interest, taxes, depreciation and amortization
How can dominance in the implant niche be ensured? The uniqueness of silicon nitride ceramics grants Sintx Technologies (SINT) full pricing power. Operating earnings before depreciation demonstrate efficiency dynamics, where 0.00 determines the latest valuation metric. Growth is driven by the integration of materials into the mass-market products of global brands and the work of a staff of top-tier biochemists under strict quality control.
Summary analytical data breakdowns for Sintx Technologies, Inc. (SINT)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Sintx Technologies|SINT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Sintx Technologies Inc|SINT - Company Aggregate Debts|Debts to Book Value Sintx Technologies|SINT - Company Long-Term Debts|Company Short-Term Indebtedness Sintx Technologies|Interim Coverage Ratio sintx.com
- earnings and market multiples details:
SINT - Net Profit|Future Profit Sintx Technologies|SINT - P/E Multiple|Forward P/E Multiple Sintx Technologies Inc|SINT - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sintx Technologies|SINT - Operating profit before deduction of amortization|Earnings per share for the trailing year Sintx Technologies|SINT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months sintx.com|SINT - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Sintx Technologies
Summary company analytics:Sintx Technologies
Conservative capital demands absolute cash flow transparency to assess business resilience against market shocks. This EBITDA metric measures average daily operating income before taxes and interest, allowing investors to evaluate the fundamental cash generation power of Sintx Technologies (SINT). The stability of this curve confirms the high margins of the unique antibacterial materials produced by Sintx Technologies (SINT), transforming a technological moat into a predictable financial result.
Who Sintx Technologies competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Operating profit EBITDA|Operating income before deduction of amortization Anika Therapeutics ANIK|InspireMD (NSPR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZJYL (Jin Medical)|Profit before payment of interest, taxes and amortization Vivani Medical Inc|Operating profit before deduction of amortization Xtant Medical Inc (XTNT)|Operating profit EBITDA NMTC|MODD - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Myomo MYO|COCH: Operating profit before amortization|VVOS: Operating profit before deduction of amortization|enVVeno Corp - Company profit before taxes, interest and amortization|Tenon Medical, Inc. (TNON) - Profit before payment of interest, taxes and amortization|LFWD - Operating income before deduction of amortization|AMIX (Autonomix Medical Inc.) - Operating profit EBITDA|INVO Bioscience (IVF) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bone Biologics Corporation (BBLG)|Axonics, Inc - Operating profit before amortization|BIOLASE, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization DYNT (Dynatronics Corp)|FNA: Operating profit before deduction of amortization|INVO (INVO Bioscience, Inc.) - Operating profit before amortization
